Mr. James Howard-Tripp reports
GENENEWS ANNOUNCES FOURTH QUARTER 2018 RESULTS AND YEAR END INVESTOR CALL
GeneNews Ltd. will release its fourth quarter 2018 results before markets open on Tuesday, April 2, 2019. GeneNews's chairman and chief executive officer, James R. Howard-Tripp, will host a conference call at 4:30 p.m. ET on April 3 to review the results and discuss business developments for the period.
Fourth quarter 2018 results conference call details
Date: Tuesday, April 3, 2019
Time: 4:30 p.m. ET
Live call (participant): 877-407-8033, 201-689-8033
Playback phone numbers
Playback expiration date: April 9, 2019
About GeneNews Ltd.
GeneNews is dedicated to developing and commercializing innovative solutions for early cancer detection. The company's mission is to provide advanced diagnostics that can help physicians identify cancer in their patients at the earliest-possible stage, when it is the most curable. In addition to building a pipeline of products for early cancer detection, GeneNews operates a CAP-accredited clinical reference lab based in Richmond, Va., that offers the ColonSentry test as well as licensed biomarker tests for lung, breast and prostate cancers.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.